Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuralWare is a pioneer in the development of artificial neural network software, providing advanced modeling tools that have been utilized in the life sciences and healthcare industries for over three decades. Founded in 1987, the company's flagship products, such as NeuralWorks Professional II/Plus and Predict, enable researchers to develop predictive models for complex biological systems, medical imaging, and pharmaceutical research. The company's technology has historically underpinned significant advancements in computer-aided diagnosis (CAD), including FDA-cleared systems for automated screening in oncology. NeuralWare remains a key provider of AI-driven analytical solutions for technical, scientific, and medical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuralWare.